Contact
searchSearch
HMP Global

January 2016 - FRMC

New Treatment Option for HYPERKALEMIA: patiromer
02/02/2016
Patients with CKD and hyperkalemia found that treatment with patiromer was associated with a reduction in serum potassium levels and a reduction in recurrence.
Patients with CKD and hyperkalemia found that treatment with patiromer was associated with a reduction in serum potassium levels and a reduction in recurrence.
Patients with CKD and...
02/02/2016
First Report Managed Care
Department
Product Update
02/02/2016
The FDA approved Zurampic (lesinurad) used in combination with a xanthine oxidase inhibitor (XOI) to treat hyperuricemia associated with gout. XOI is used to reduce the production of uric acid in the body.
The FDA approved Zurampic (lesinurad) used in combination with a xanthine oxidase inhibitor (XOI) to treat hyperuricemia associated with gout. XOI is used to reduce the production of uric acid in the body.
The FDA approved Zurampic...
02/02/2016
First Report Managed Care
NON–SMALL-CELL LUNG CANCER: Shifting from Generic Chemotherapy Regimens to Complex Treatment Landscapes
02/02/2016
Eileen Koutnik-Fotopoulos
With new drugs targeting second-line therapy, a crowded treatment algorithm may be on the horizon for patients with NSCLC. 
With new drugs targeting second-line therapy, a crowded treatment algorithm may be on the horizon for patients with NSCLC. 
With new drugs targeting...
02/02/2016
First Report Managed Care
Specialty Drugs: The Tipping Point is Coming
02/02/2016
Eileen Koutnik-Fotopoulos
Payer clients are faced with alarmingly high-cost specialty drug trends with no clear direction on how to balance the dilemma of therapy versus cost. Add the explosive development of new specialty drugs over the next few years and payers...
Payer clients are faced with alarmingly high-cost specialty drug trends with no clear direction on how to balance the dilemma of therapy versus cost. Add the explosive development of new specialty drugs over the next few years and payers...
Payer clients are faced with...
02/02/2016
First Report Managed Care
US Just Scratching Surface of Biosimilar Landscape
02/02/2016
Eileen Koutnik-Fotopoulos
Now that the first biosimilar—filgrastim-sndz—has entered the US marketplace, policies and perceptions around these complex medicines are unfurling.
Now that the first biosimilar—filgrastim-sndz—has entered the US marketplace, policies and perceptions around these complex medicines are unfurling.
Now that the first...
02/02/2016
First Report Managed Care
Should Medicare Negotiate Drug Prices?
02/02/2016
Dean Celia
Drug costs are a top concern for voters, with polls showing that most are open to letting Medicare tackle the issue by negotiating drug prices. Here’s where the presidential candidates stand and what our experts believe are the potential...
Drug costs are a top concern for voters, with polls showing that most are open to letting Medicare tackle the issue by negotiating drug prices. Here’s where the presidential candidates stand and what our experts believe are the potential...
Drug costs are a top concern...
02/02/2016
First Report Managed Care
New Breast Cancer Guidelines and Managed Care
02/02/2016
Dean Celia
The American Cancer Society's revised guidelines have inched closer to United States Preventive Services Task Force recommendations. How will this impact managed care? Our experts sort through the potential effect on Accountable Care...
The American Cancer Society's revised guidelines have inched closer to United States Preventive Services Task Force recommendations. How will this impact managed care? Our experts sort through the potential effect on Accountable Care...
The American Cancer...
02/02/2016
First Report Managed Care
Embracing Change: As the Number of Public and Private ACOs Grow, Lessons Emerge
02/02/2016
Jill Sederstorm
The momentum to establish accountable care organizations (ACOs) continues to grow, as both government and commercial payers make a push for providers to begin baring risk for patient populations. 
The momentum to establish accountable care organizations (ACOs) continues to grow, as both government and commercial payers make a push for providers to begin baring risk for patient populations. 
The momentum to establish...
02/02/2016
First Report Managed Care
Hello, Goodbye—Implications of UnitedHealth`s Potentially Quick ACA Exit
02/02/2016
Paul Nicolaus
Is a fundamental structural issue with the exchange products overall to blame? Our experts think only time will tell. 
Is a fundamental structural issue with the exchange products overall to blame? Our experts think only time will tell. 
Is a fundamental structural...
02/02/2016
First Report Managed Care
Challenges in Oncology Care Management
02/02/2016
Jill Sederstorm
The percentage of MCOs using guidelines and pathways to direct cancer treatment is on the rise. 
The percentage of MCOs using guidelines and pathways to direct cancer treatment is on the rise. 
The percentage of MCOs using...
02/02/2016
First Report Managed Care
Perception of Trust Has Positive Impact on Performance in Buyer-seller Relationship
02/02/2016
Mary Mihalovic
Trust between buyers and suppliers in the health sector is defined as a firm’s belief that the other will act in the best interest of the firm and the relationship, and is definitely perceived to improve performance (defined as the impact...
Trust between buyers and suppliers in the health sector is defined as a firm’s belief that the other will act in the best interest of the firm and the relationship, and is definitely perceived to improve performance (defined as the impact...
Trust between buyers and...
02/02/2016
First Report Managed Care
Newsfeed
Efforts to Implement PCMH Concepts Can Lead to Big Cost Savings for States
02/02/2016
Jill Sederstorm
As 1 of 8 states to conduct a Multi-Payer Advanced Primary Care Practice demonstration project aimed to evaluate the effectiveness of patient-centered medical homes when Medicaid, Medicare, and private payers support it, North Carolina and...
As 1 of 8 states to conduct a Multi-Payer Advanced Primary Care Practice demonstration project aimed to evaluate the effectiveness of patient-centered medical homes when Medicaid, Medicare, and private payers support it, North Carolina and...
As 1 of 8 states to conduct a...
02/02/2016
First Report Managed Care
Generic and Traditional Drugs Also Influence High Costs
02/02/2016
Mary Beth Nierengarten
Along with the high cost of specialty drugs, newly branded and first-time generic drugs will impact drug spending in 2016. 
Along with the high cost of specialty drugs, newly branded and first-time generic drugs will impact drug spending in 2016. 
Along with the high cost of...
02/02/2016
First Report Managed Care
Newsfeed
Virtual Health Assistants: Influencing Patient Behavior to Improve Health Outcomes
02/02/2016
Melissa D. Cooper
Patient behavior can be critical to health outcomes, but how can these individuals’ behavior be influenced to improve health care outcomes? Virtual health assistants, Thomas Morrow, MD, chief medical officer, Next IT, said during the second...
Patient behavior can be critical to health outcomes, but how can these individuals’ behavior be influenced to improve health care outcomes? Virtual health assistants, Thomas Morrow, MD, chief medical officer, Next IT, said during the second...
Patient behavior can be critical...
02/02/2016
First Report Managed Care
Conference Insider
Using the MSSP ACO Model in a PCP-centric Solution Impacts Overall Costs, Improves Care
02/02/2016
Mary Mihalovic
Physician group practice cost and expense findings show primary care involvement impacts overall costs, giving rise to the PCP-centric solution. 
Physician group practice cost and expense findings show primary care involvement impacts overall costs, giving rise to the PCP-centric solution. 
Physician group practice...
02/02/2016
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

January 2016 Volume 13 Issue 1

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use